Session Details

U025 Cases in Genetic Skin Diseases: Clinicopathological Clues

Sat, Mar 20, 7:30 AM - 8:30 AM
1 CME Available Focus Session

DESCRIPTION

This session will highlight clinicopathologic clues that support the diagnosis of genetic skin diseases and show how integrating clinical findings, dermatopathology, and genetic testing can lead to earlier diagnosis and more precise management. Expert clinicians and investigators will discuss practical diagnostic patterns, genotype phenotype correlations, and real world approaches to multidisciplinary care. Cases will emphasize how to recognize key findings, avoid diagnostic delay, and use pathology and genetics to guide counseling, surveillance, and treatment. This session is designed for dermatologists, dermatopathologists, pediatric dermatologists, trainees, and others interested in genodermatoses and complex diagnostic care.

LEARNING OBJECTIVES

1.

Diagnose clinical signs of genetic skin diseases more effectively

2.

Recognize the dermatopathological clues pointing to genetic skin diseases

3.

Effectively utilize and integrate clinicopathological correlation with genetic testing

SCHEDULE

7:30 AM

Discussion

DIRECTOR

Nessa Aghazadeh Monandesi, MD, FAAD

Nessa Aghazadeh Monandesi, MD, FAAD

Mayo Clinic

SPEAKERS

Shruti Agrawal, MD, FAAD

Shruti Agrawal, MD, FAAD

Harper Price, MD, FAAD

Harper Price, MD, FAAD

DISCLOSURES

Nessa Aghazadeh Monandesi, MD, FAAD

Abeona Therapeutics – Advisory Board(Honoraria); AlphaSights – Consultant (1099 relationship)(Fees); Chiesi Farmaceutici – Advisory Board(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); Mosaic Research Management – Consultant (1099 relationship)(Fees); The Dedham Group – Consultant (1099 relationship)(Fees);

Shruti Agrawal, MD, FAAD

No financial relationships exist with ineligible companies.

Harper Price, MD, FAAD

No financial relationships exist with ineligible companies.